Haleon trades up after smaller than expected GSK sale
![A logo sign outside of a facility occupied by GlaxoSmithKline (GSK) in Philadelphia, Pennsylvania on November 7, 2015.](https://assets.euromoneydigital.com/dims4/default/512d82f/2147483647/strip/true/crop/4000x2667+0+0/resize/840x560!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2Fdc%2F31%2Fafb0422841e3bc720e41f24fd039%2Ff62f6j.jpg)
In a block trade, GSK sold 2.6% of its former joint venture with Pfizer
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
The content you are trying to view is exclusive to our subscribers.
To unlock this article: